Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Current Medicinal Chemistry|April 14, 2004
The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidateT D Bradshaw, A D WestwellInternational Journal of Cancer|April 22, 1992
Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in A549 human lung-carcinoma cellsT D Bradshaw, A Gescher, G R PettitInternational Journal of Cancer|April 1, 1991
The effect of fetal calf serum on growth arrest caused by activators of protein kinase CT D Bradshaw, A Gescher, G R PettitInternational Journal of Cancer|August 15, 1989
Sterically hindered analogues of diacylglycerols. Synthesis, binding to the phorbol ester receptor and metabolism in A549 human lung carcinoma cellsC A Laughton, T D Bradshaw, A GescherCurrent Medicinal Chemistry|February 15, 2001
The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compoundsT D Bradshaw, M F Stevens, A D WestwellInternational Journal of Cancer|February 15, 1994
The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cellsC Stanwell, A Gescher, T D Bradshaw, et al.Cancer Research|June 15, 1989
Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cellsI L Dale, T D Bradshaw, A Gescher, et al.Current Pharmaceutical Design|October 9, 2002
The aryl hydrocarbon receptor in anticancer drug discovery: friend or foe?T D Bradshaw, V Trapani, D A Vasselin, et al.Soft Matter|October 8, 2016
Developing a self-healing supramolecular nucleoside hydrogelK J Skilling, B Kellam, M Ashford, et al.British Journal of Cancer|July 20, 2000
Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445)T D Bradshaw, M S Chua, S Orr, et al.Pageof 3